ARTICLE | Company News
Cytogen, Neoprobe deal
June 10, 1996 7:00 AM UTC
NEOP signed a letter of intent to manufacture its RIGS/ACT activated cell therapy product using the cell processing and development manufacturing facility in Needham, Mass., operated by CYTO's Cellcor...